Waystar (WAY) Q1 2025: Net Revenue Retention Hits 114% as AI-Driven Upsell Accelerates

2025-04-30 | By EarningsIQ Research

Waystar’s Q1 2025 results spotlight a resilient, compounding growth engine powered by high-value AI innovation and embedded client relationships. Net revenue retention surged to 114%, reflecting robust cross-sell and rapid onboarding amid a competitive, recession-resistant healthcare payments landscape. Raised guidance underscores management’s conviction in the durability of demand and the monetization potential of AI-driven workflow automation, with patient payment utilization and subscription expansion as key levers for the year ahead.

Summary

• AI Monetization: Early adoption of Altitude AI and automation modules is driving rapid upsell and measurable ROI for providers.
• Retention Engine: Net revenue retention at 114% reflects durable client expansion and cross-sell from accelerated onboarding.
• Guidance Confidence: Raised full-year outlook signals visibility into continued compounding growth and operational leverage.

Performance Analysis

Waystar delivered a 14% year-over-year revenue increase in Q1 2025, with adjusted EBITDA up 16%, underscoring the high-margin, recurring nature of its healthcare payments software model. The business continues to benefit from a dual-revenue approach: subscription-based revenue, which grew 18% YoY, and volume-based revenue, which, after normalizing for one-time factors, rose about 12% YoY. Notably, subscription revenue’s outperformance was driven by rapid onboarding of new clients in the wake of a competitor clearinghouse cyberattack, with $10 million of incremental Q1 revenue recognized from faster implementations.

Patient payment solutions, now comprising 30% of total revenue, saw elevated utilization, particularly in the first half of the year as deductible resets boost transaction volume. Unlevered free cash flow conversion reached 73%, reinforcing the company’s ability to invest in innovation, reduce leverage (now at 2.5x net debt/EBITDA), and pursue disciplined M&A. Management highlighted that 98% of annual revenue is secured through contracted solutions at the start of the year, providing strong visibility and insulation from macro volatility.

• Embedded Workflow Advantage: Over 1,244 clients now generate more than $100,000 in trailing revenue, up 15% YoY, illustrating deepening client penetration.
• Patient Payment Tailwind: Continued strength in patient payment utilization contributed to guidance raise, with management flagging potential upside if this trend persists.
• Volume Normalization Ahead: Q1 benefited from one-off onboarding and utilization spikes; the remainder of 2025 is expected to see more modest sequential growth.

Waystar’s model demonstrates resilience and operating leverage, with high retention, expanding cross-sell, and strong cash generation positioning the company for sustainable, compounding growth even as one-time onboarding effects normalize.

Executive Commentary

Strategic Positioning

1. AI-Driven Product Expansion

Altitude AI, Waystar’s generative AI suite, is rapidly becoming a core differentiator. Early adopters report an 85% auto-approval rate for prior authorizations and a 70% reduction in staff time, while AI-powered appeals deliver 40% higher overturn rates. These results are fueling both cross-sell and new module adoption, with management noting that large provider organizations are now allocating incremental, non-traditional budgets for Gen AI-enabled solutions. This signals a structural shift in healthcare IT spend, positioning Waystar to capture both wallet share and new use cases as automation becomes a budgeted imperative.

2. Embedded, Mission-Critical Workflow

Waystar’s platform is deeply embedded across over a million U.S.-based providers, spanning large integrated delivery networks and small practices. This workflow integration underpins high net revenue retention and provides insulation from macro shocks, with 98% of revenue contracted at year start. Mission-critical status drives sticky relationships and creates a durable upsell channel, especially as clients seek efficiency and cash flow optimization in volatile conditions.

3. Cross-Sell and Upsell Momentum

Net revenue retention of 114% is the clearest signal of successful cross-sell and upsell, driven by both rapid onboarding of clients fleeing competitor disruptions and the expansion of existing relationships. Management highlighted that 30% of clients impacted by last year’s competitor outage are actively engaged in cross-sell dialogues, and Q1 saw “nice adoption” of additional modules within this cohort. The platform’s modularity and rapid deployment capability enable efficient expansion within the installed base, supporting durable double-digit growth.

4. Operational Efficiency and Client Experience

Industry-leading client support metrics—70% of service requests resolved same-day and 90% of calls answered within 30 seconds— reinforce Waystar’s brand as a trusted partner. The company’s investment in automation and U.S.-based support not only enhances client satisfaction but also drives scalable operating leverage, supporting stable 40% EBITDA margins even as innovation and cybersecurity investments ramp.

5. Disciplined Capital Allocation and M&A

With leverage at 2.5x and $224 million in cash, Waystar is positioned to pursue disciplined M&A, targeting technology, people, and client bases that integrate seamlessly into the core platform. Management’s track record of integrating acquisitions and driving cross-platform benefits remains a strategic lever for future growth, particularly in a fragmented healthcare IT landscape.

Key Considerations

Waystar’s Q1 performance reflects a business model built for resilience and compounding growth, with AI innovation unlocking incremental wallet share and embedded workflow positioning the company as a mission-critical partner for providers navigating complexity and volatility.

Key Considerations:

• AI Adoption Curve: Large provider organizations are beginning to allocate dedicated budgets for Gen AI solutions, but broad-based adoption is still early-stage, representing a multi-year growth vector.
• Utilization Trends: Elevated patient payment utilization in Q1 drove outperformance, but guidance assumes normalization in the back half of the year; continued strength could provide further upside.
• Cross-Sell Opportunity: 30% of clients onboarded during last year’s competitor outage are in active cross-sell discussions, with early signs of incremental module adoption.
• Volume-Based Seasonality: Patient payment solutions are front-loaded in the year due to deductible resets, with sequential revenue growth expected to moderate as the year progresses.
• Capital Allocation Flexibility: Strong cash flow and reduced leverage equip Waystar to invest in innovation, client expansion, and targeted M&A as consolidation opportunities arise.

Risks

Waystar’s recession-resistant model is not immune to macro shocks, particularly if patient payment utilization declines or economic stress erodes patients’ ability to pay. While management sees no current degradation, a reversal in utilization or a major provider downturn could pressure volume-based revenue. The normalization of one-time onboarding effects may also create tougher YoY comps in future quarters. Regulatory changes, while not expected to impact 2025, remain a longer-term watchpoint.

Forward Outlook

For Q2 2025, Waystar guided to:

• Modest sequential subscription revenue growth as onboarding effects normalize
• Volume-based revenue tracking with patient payment seasonality and utilization trends

For full-year 2025, management raised guidance:

• Revenue range of $1.16 billion to $1.22 billion, $6 million increase at midpoint
• Adjusted EBITDA range of $406 million to $414 million, midpoint up $7 million

Management cited strong contracted revenue visibility, continued cross-sell momentum, and the durability of patient payment utilization as key drivers for the guidance raise. Upside could materialize if elevated utilization persists; downside risk centers on any sudden drop in patient payment activity or macro-driven provider stress.

• Cross-sell and AI module adoption remain key upside levers
• Volume normalization expected in back half; monitoring utilization trends closely

Takeaways

Waystar’s Q1 results reinforce its position as a high-retention, high-margin compounding platform, with AI innovation and workflow integration driving both cross-sell and operational leverage.

• Retention and Upsell Engine: 114% net revenue retention signals durable expansion and the power of embedded client relationships.
• AI Monetization in Early Innings: Early results from Altitude AI and automation modules are translating into measurable client ROI and incremental revenue, with broad-based adoption still ahead.
• Watch Utilization and Seasonality: Patient payment strength drove the quarter; normalization in later quarters will test the durability of volume-based growth.

Conclusion

Waystar’s Q1 2025 performance demonstrates a resilient, compounding business model, with AI-driven innovation and embedded workflow positioning the company for durable growth. Raised guidance and high net revenue retention provide visibility, but investors should monitor utilization trends and the pace of AI adoption as key swing factors for the remainder of the year.

Industry Read-Through

Waystar’s results highlight the growing imperative for automation and AI in healthcare payments, with providers increasingly prioritizing solutions that drive ROI, efficiency, and cash flow optimization. The shift toward dedicated AI budgets and the insourcing of revenue cycle management tasks signal broader disruption for traditional BPO and manual workflow vendors. Vendors able to deliver embedded, mission-critical platforms with demonstrable ROI will capture share as providers seek resilience and efficiency in an uncertain macro environment. Watch for further acceleration of AI module adoption and workflow automation across the healthcare IT sector.

WAY Healthcare Healthcare IT Automation Artificial Intelligence Recurring Revenue Workflow